Company Celltrion, Inc.

Equities

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. 23:00:00 11/07/2024 BST 5-day change 1st Jan Change
188,800 KRW +1.61% Intraday chart for Celltrion, Inc. +1.61% -6.30%

Business Summary

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Number of employees: 2,034

Sales per Business

KRW in Million2022Weight2023Weight Delta
Biopharmaceutical
86.1 %
1,937,469 84.8 % 1,873,430 86.1 % -3.31%
Chemical Drugs
23.0 %
653,519 28.6 % 500,777 23.0 % -23.37%
Reconciling Items
-9.3 %
-310,898 -13.6 % -202,919 -9.3 % -34.73%
Others
0.2 %
3,877 0.2 % 5,143 0.2 % +32.66%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
97.1 %
2,090,465 91.5 % 2,113,156 97.1 % +1.09%
Asia
2.9 %
62,069 2.7 % 63,275 2.9 % +1.94%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 23/04/07
Director of Finance/CFO 49 -
Chairman 66 -
Compliance Officer 42 -
Corporate Officer/Principal 54 -
Corporate Officer/Principal 57 -
Corporate Officer/Principal 61 -
Corporate Officer/Principal 57 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 73 -
Chairman 66 -
Director/Board Member 72 07/12/14
Director/Board Member 66 16/07/08
Director/Board Member 64 19/03/09
Director/Board Member 66 26/03/14
Director/Board Member 64 -
Director/Board Member 65 -
Director/Board Member 61 -
Director/Board Member 48 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 215,109,440 143,883,915 ( 66.89 %) 11,199,208 ( 5.206 %) 66.89 %

Shareholders

NameEquities%Valuation
60,012,150 27.66 % 7 599 M ₩
National Pension Service of Korea
6.237 %
13,534,497 6.237 % 1 714 M ₩
Temasek Holdings Pte Ltd. (Investment Management)
2.545 %
5,523,531 2.545 % 699 M ₩
4,508,124 2.078 % 571 M ₩
Celltrion Inc. Employee Stock Ownership ASSN.
0.2473 %
536,669 0.2473 % 68 M ₩
State Street Global Advisors Ltd.
0.1364 %
296,052 0.1364 % 37 M ₩
Sjunde AP-fonden
0.1277 %
277,089 0.1277 % 35 M ₩
250,384 0.1154 % 32 M ₩
205,618 0.0948 % 26 M ₩
184,444 0.0850 % 23 M ₩

Holdings

NameEquities%Valuation
22,797,613 54.81% 1,470,706,843 $
4,508,124 2.08% 570,843,456 $
1,631,134 10.22% 5,711,628 $

Company contact information

Celltrion, Inc.

23 Academy-ro Yeonsu-gu

22014, Inchon

+

http://www.celltrion.com
address Celltrion, Inc.(A068270)